{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:26:07Z","timestamp":1791321967912,"version":"4.3.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2012,5,21]],"date-time":"2012-05-21T00:00:00Z","timestamp":1337558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,5,21]],"date-time":"2012-05-21T00:00:00Z","timestamp":1337558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2013,3,28]]},"DOI":"10.1038\/onc.2012.177","type":"journal-article","created":{"date-parts":[[2012,5,21]],"date-time":"2012-05-21T13:17:19Z","timestamp":1337606239000},"page":"1724-1734","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma"],"prefix":"10.1038","volume":"32","author":[{"given":"X","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Sekido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,5,21]]},"reference":[{"key":"BFonc2012177_CR1","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.jhep.2004.09.006","volume":"41","author":"D Semela","year":"2004","unstructured":"Semela D, Dufour JF . Angiogenesis and hepatocellular carcinoma. J Hepatol 2004; 41: 864\u2013880.","journal-title":"J Hepatol"},{"key":"BFonc2012177_CR2","first-page":"1900","volume":"6","author":"A Eggert","year":"2000","unstructured":"Eggert A, Ikegaki N, Kwiatkowski J, Zhao H, Brodeur GM, Himelstein BP . High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. Clin Cancer Res 2000; 6: 1900\u20131908.","journal-title":"Clin Cancer Res"},{"key":"BFonc2012177_CR3","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1159\/000096774","volume":"38","author":"FK Doger","year":"2006","unstructured":"Doger FK, Meteoglu I, Tuncyurek P, Okyay P, Cevikel H . Does the EGFR and VEGF expression predict the prognosis in colon cancer? Eur Surg Res 2006; 38: 540\u2013544.","journal-title":"Eur Surg Res"},{"key":"BFonc2012177_CR4","doi-asserted-by":"publisher","first-page":"790","DOI":"10.5754\/hge10541","volume":"58","author":"HJ Cha","year":"2011","unstructured":"Cha HJ, Lee HH, Chae SW, Cho WJ, Kim YM, Choi HJ et alTristetraprolin downregulates the expression of both VEGF and COX-2 in human colon cancer. Hepatogastroenterology 2011; 58: 790\u2013795.","journal-title":"Hepatogastroenterology"},{"key":"BFonc2012177_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrd2115","volume":"6","author":"J Folkman","year":"2007","unstructured":"Folkman J . Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 2007; 6: 273\u2013286.","journal-title":"Nat Rev Drug Discov"},{"key":"BFonc2012177_CR6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF et alSorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359: 378\u2013390.","journal-title":"N Engl J Med"},{"key":"BFonc2012177_CR7","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nrclinonc.2011.30","volume":"8","author":"AX Zhu","year":"2011","unstructured":"Zhu AX, Duda DG, Sahani DV, Jain RK . HCC and angiogenesis: possible targets and future directions. Nat Rev Clin Oncol 2011; 8: 292\u2013301.","journal-title":"Nat Rev Clin Oncol"},{"key":"BFonc2012177_CR8","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1172\/JCI200421152","volume":"114","author":"K Watanabe","year":"2004","unstructured":"Watanabe K, Hasegawa Y, Yamashita H, Shimizu K, Ding Y, Abe M et alVasohibin as an endothelium-derived negative feedback regulator of angiogenesis. J Clin Invest 2004; 114: 898\u2013907.","journal-title":"J Clin Invest"},{"key":"BFonc2012177_CR9","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/j.1349-7006.2010.01812.x","volume":"102","author":"K Yoshinaga","year":"2011","unstructured":"Yoshinaga K, Ito K, Moriya T, Nagase S, Takano T, Niikura H et alRoles of intrinsic angiogenesis inhibitor, vasohibin, in cervical carcinomas. Cancer Sci 2011; 102: 446\u2013451.","journal-title":"Cancer Sci"},{"key":"BFonc2012177_CR10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1349-7006.2008.01015.x","volume":"100","author":"K Tamaki","year":"2009","unstructured":"Tamaki K, Moriya T, Sato Y, Ishida T, Maruo Y, Yoshinaga K et alVasohibin-1 in human breast carcinoma: a potential negative feedback regulator of angiogenesis. Cancer Sci 2009; 100: 88\u201394.","journal-title":"Cancer Sci"},{"key":"BFonc2012177_CR11","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1161\/01.ATV.0000216747.66660.26","volume":"26","author":"T Shibuya","year":"2006","unstructured":"Shibuya T, Watanabe K, Yamashita H, Shimizu K, Miyashita H, Abe M et alIsolation and characterization of vasohibin-2 as a homologue of VEGF-inducible endothelium-derived angiogenesis inhibitor vasohibin. Arterioscler Thromb Vasc Biol 2006; 26: 1051\u20131057.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFonc2012177_CR12","doi-asserted-by":"publisher","first-page":"4810","DOI":"10.1182\/blood-2008-07-170316","volume":"113","author":"H Kimura","year":"2009","unstructured":"Kimura H, Miyashita H, Suzuki Y, Kobayashi M, Watanabe K, Sonoda H et alDistinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis. Blood 2009; 113: 4810\u20134818.","journal-title":"Blood"},{"key":"BFonc2012177_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/47412","volume":"403","author":"BD Strahl","year":"2000","unstructured":"Strahl BD, Allis CD . The language of covalent histone modifications. Nature 2000; 403: 41\u201345.","journal-title":"Nature"},{"key":"BFonc2012177_CR14","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1126\/science.1063127","volume":"293","author":"T Jenuwein","year":"2001","unstructured":"Jenuwein T, Allis CD . Translating the histone code. Science 2001; 293: 1074\u20131080.","journal-title":"Science"},{"key":"BFonc2012177_CR15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nature01080","volume":"419","author":"H Santos-Rosa","year":"2002","unstructured":"Santos-Rosa H, Schneider R, Bannister AJ, Sherriff J, Bernstein BE, Emre NC et alActive genes are tri-methylated at K4 of histone H3. Nature 2002; 419: 407\u2013411.","journal-title":"Nature"},{"key":"BFonc2012177_CR16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1126\/science.1084274","volume":"300","author":"K Plath","year":"2003","unstructured":"Plath K, Fang J, Mlynarczyk-Evans SK, Cao R, Worringer KA, Wang H et alRole of histone H3 lysine 27 methylation in X inactivation. Science 2003; 300: 131\u2013135.","journal-title":"Science"},{"issue":"Part 24","key":"BFonc2012177_CR17","doi-asserted-by":"publisher","first-page":"5825","DOI":"10.1242\/jcs.02689","volume":"118","author":"SM Gorisch","year":"2005","unstructured":"Gorisch SM, Wachsmuth M, Toth KF, Lichter P, Rippe K . Histone acetylation increases chromatin accessibility. J Cell Sci 2005; 118 (Part 24): 5825\u20135834.","journal-title":"J Cell Sci"},{"issue":"Part 18","key":"BFonc2012177_CR18","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1242\/jcs.067538","volume":"123","author":"Y Suzuki","year":"2010","unstructured":"Suzuki Y, Kobayashi M, Miyashita H, Ohta H, Sonoda H, Sato Y . Isolation of a small vasohibin-binding protein (SVBP) and its role in vasohibin secretion. J Cell Sci 2010; 123 (Part 18): 3094\u20133101.","journal-title":"J Cell Sci"},{"key":"BFonc2012177_CR19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.stem.2010.08.013","volume":"7","author":"D Palacios","year":"2010","unstructured":"Palacios D, Mozzetta C, Consalvi S, Caretti G, Saccone V, Proserpio V et alTNF\/p38alpha\/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration. Cell Stem Cell 2010; 7: 455\u2013469.","journal-title":"Cell Stem Cell"},{"key":"BFonc2012177_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10456-011-9206-4","volume":"14","author":"R Tammali","year":"2011","unstructured":"Tammali R, Reddy AB, Srivastava SK, Ramana KV . Inhibition of aldose reductase prevents angiogenesis in vitro and in vivo. Angiogenesis 2011; 14: 209\u2013221.","journal-title":"Angiogenesis"},{"key":"BFonc2012177_CR21","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.bbrc.2007.05.125","volume":"359","author":"J Mi","year":"2007","unstructured":"Mi J, Zhang X, Liu Y, Reddy SK, Rabbani ZN, Sullenger BA et alNF-kappaB inhibition by an adenovirus expressed aptamer sensitizes TNFalpha-induced apoptosis. Biochem Biophys Res Commun 2007; 359: 475\u2013480.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFonc2012177_CR22","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/ar.20668","volume":"291","author":"ZF Yang","year":"2008","unstructured":"Yang ZF, Poon RT . Vascular changes in hepatocellular carcinoma. Anat Rec (Hoboken) 2008; 291: 721\u2013734.","journal-title":"Anat Rec (Hoboken)"},{"key":"BFonc2012177_CR23","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1111\/j.1440-1746.2007.04997.x","volume":"22","author":"XZ Wu","year":"2007","unstructured":"Wu XZ, Xie GR, Chen D . Hypoxia and hepatocellular carcinoma: the therapeutic target for hepatocellular carcinoma. J Gastroenterol Hepatol 2007; 22: 1178\u20131182.","journal-title":"J Gastroenterol Hepatol"},{"key":"BFonc2012177_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/ncponc0403","volume":"3","author":"RK Jain","year":"2006","unstructured":"Jain RK, Duda DG, Clark JW, Loeffler JS . Lessons from phase III clinical trials on anti-VEGF therapy for cancer. Nat Clin Pract Oncol 2006; 3: 24\u201340.","journal-title":"Nat Clin Pract Oncol"},{"key":"BFonc2012177_CR25","doi-asserted-by":"publisher","first-page":"7021","DOI":"10.1158\/0008-5472.CAN-11-1693","volume":"71","author":"B Sitohy","year":"2011","unstructured":"Sitohy B, Nagy JA, Jaminet SC, Dvorak HF . Tumor surrogate blood vessel subtypes exhibit differential susceptibility to anti-VEGF therapy. Cancer Res 2011; 71: 7021\u20137028.","journal-title":"Cancer Res"},{"key":"BFonc2012177_CR26","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/sj.bjc.6605724","volume":"103","author":"F Wang","year":"2010","unstructured":"Wang F, Xue X, Wei J, An Y, Yao J, Cai H et alhsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations. Br J Cancer 2010; 103: 567\u2013574.","journal-title":"Br J Cancer"},{"key":"BFonc2012177_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/978-1-59745-241-0_9","volume":"467","author":"SA Eccles","year":"2009","unstructured":"Eccles SA, Court W, Patterson L, Sanderson S . In vitro assays for endothelial cell functions related to angiogenesis: proliferation, motility, tubular differentiation, and proteolysis. Method Mol Biol 2009; 467: 159\u2013181.","journal-title":"Method Mol Biol"},{"key":"BFonc2012177_CR28","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1124\/mol.105.011254","volume":"68","author":"LZ Liu","year":"2005","unstructured":"Liu LZ, Fang J, Zhou Q, Hu X, Shi X, Jiang BH . Apigenin inhibits expression of vascular endothelial growth factor and angiogenesis in human lung cancer cells: implication of chemoprevention of lung cancer. Mol Pharmacol 2005; 68: 635\u2013643.","journal-title":"Mol Pharmacol"},{"key":"BFonc2012177_CR29","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/BF00666038","volume":"36","author":"N Weidner","year":"1995","unstructured":"Weidner N . Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 1995; 36: 169\u2013180.","journal-title":"Breast Cancer Res Treat"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2012177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2012177","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2012177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T18:22:58Z","timestamp":1647886978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2012177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,21]]},"references-count":29,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2013,3,28]]}},"alternative-id":["BFonc2012177"],"URL":"https:\/\/doi.org\/10.1038\/onc.2012.177","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,21]]},"assertion":[{"value":"17 November 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}